Evaluation of the use of a patient questionnaire in measuring patient reported outcomes of medication reviews
Completed
- Conditions
- adverse drug reactions (ADRs), side effects of drugs, medication adherence (MARS), beliefs about medicines necessity and concerns (BMQ), self efficacy (MUSE)
- Registration Number
- NL-OMON28732
- Lead Sponsor
- Radboud university medical center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
Patients eligible for a community pharmacist-led medication review according to the guidelines (use of 5 or more prescribed chronic systemic drugs).
Other criteria to achieve the intended study population of 20 patients per pharmacy to be determined by the pharmacist, like: age over 65, specific chronic diseases, general practitioner (GP) of the patient.
Exclusion Criteria
To be assessed by the community pharmacists considering:
- cognitive or communication impairments;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total number of ADRs, as reported through the PROM questionnaire at follow up measurement.
- Secondary Outcome Measures
Name Time Method Patient reported scores on health perception, beliefs about medication (BMQ) necessity, beliefs about medication (BMQ) concerns, self efficacy (MUSE), and medication adherence (MARS) at follow up measurement.<br /><br>Change of the number of patients who report ADRs at follow up measurement.<br /><br>Change of the ADRs that were reported at baseline at follow up measurement compared between the intervention and the control group.<br>